Skip to main content
Jan Nowak, MD, Pathology, Buffalo, NY

JanAnthonyNowakMDPhD

Pathology Buffalo, NY

Cytopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Clinical Chief of Molecular Pathology, Roswell Park Comprehensive Cancer Center

Dr. Nowak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nowak's full profile

Already have an account?

  • Office

    Elm and Carlton St
    Buffalo, NY 14263
    Phone+1 716-845-2300
    Fax+1 716-845-3427

Education & Training

  • University of Rochester
    University of RochesterResidency, Pathology-Anatomic and Clinical, 1984 - 1988
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1984
  • University of California Division of Agriculture and Natural Resources
    University of California Division of Agriculture and Natural ResourcesNo Degree, 1978 - 1980
  • University of Rochester
    University of RochesterPh.D., Biophysics, 1973 - 1979
  • Canisius College
    Canisius CollegeB.S., Chemistry, 1969 - 1973

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1985 - 2026
  • IL State Medical License
    IL State Medical License 1992 - 2017
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Molecular Genetic Pathology

Awards, Honors, & Recognition

  • Leadership Award Association for Molecular Pathology, 2013
  • Junior Fellowship, California Division (declined) American Cancer Society, 1978
  • Postdoctoral Fellowship (declined) American Cancer Society, 1978
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization  
    Ali SM, et al (JA Nowak), Oncologist, 1/1/2016
  • The cancer genome resource list 2014  
    Zutter, MM, et al (JA Nowak), Arch Pathol Lab Med, 1/1/2015
  • Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular Pathology  
    Ferreira-Gonzalez, A, et al (JA Nowak), J Mol Diagn, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • A non-bisulfite based DNA methylation assay to detect MGMT promoter methylation
    Sabatini, LM, Nowak, JA, Bouma, M, Krispin, M, and Petrisko, J, Association for Molecular Pathology, Washington, DC, 1/13/2014
  • Molecular Cytology: next generation sequencing of tumor cells recovered from Papanicolaou stained cytologic smears
    Sabatini, LM, Bouma, M, and Nowak, J, Association for Molecular Pathology, Washington, DC, 1/13/2014
  • Molecular Cytology: Validation of a Method for the Direct Molecular Evaluation of Pap Stained Cellular Material
    Gibson, WE and JA Nowak, US - Canadian Academy of Pathology Annual Meeting, San Diego, CA, 1/2/2014
  • Join now to see all

Lectures

  • Molecular Pathology Tests for Prognosis in Common Cancers 
    Baltimore, MD - 1/24/2015
  • Emerging Concepts in Anatomic Pathology 
    Tucson, AZ - 1/16/2015
  • Understanding and Avoiding Common Quality Deficiencies in Anatomic Pathology 
    Tucson, AZ - 1/16/2015
  • Join now to see all

Other

Authored Content

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018

Press Mentions

  • College of American Pathologists (CAP) Recognizes Doctors for Dedicated Service
    College of American Pathologists (CAP) Recognizes Doctors for Dedicated ServiceOctober 5th, 2017
  • AMP Issues Statement Regarding FDA Letter to Texas Children’s Hospital And
    AMP Issues Statement Regarding FDA Letter to Texas Children’s Hospital AndMarch 14th, 2016